| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $798.7M | +16.9% |
| Cost of Revenue | $183.6M | +18.6% |
| Gross Profit | $615.1M | +16.4% |
| R&D Expense | $153.2M | +6.7% |
| SG&A Expense | $116.2M | +12.5% |
| Operating Income | -$52.2M | +23.1% |
| Interest Expense | $31.3M | +64.9% |
| Income Tax | $10.9M | +57.0% |
| Net Income | -$78.3M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $237.1M | -21.2% |
| Short-term Investments | $236.8M | -11.2% |
| Accounts Receivable | $220.1M | +17.5% |
| Current Assets | $805.5M | -6.0% |
| Total Assets | $1.61B | +11.6% |
| Current Liabilities | $675.8M | +15.7% |
| Total Liabilities | $1.26B | +7.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $149.9M | +14.3% |
| Capital Expenditures | $1.7M | -81.8% |
| Investing Cash Flow | -$212.6M | -66.1% |
| Financing Cash Flow | $1.3M | -94.6% |
| Free Cash Flow | $148.2M | +21.6% |
| +15.1% |
| EPS (Basic) | -$0.68 | +18.1% |
| EPS (Diluted) | -$0.68 | +18.1% |
| Stockholders' Equity |
| $346.3M |
| +27.9% |